Israel Active

At least it can in heart-diseased mice.  Scientists at Israel’s Technion Institute induced positive emotion and motivation, resulting in an immune response that helped heal cardiac scarring, increased blood vessel formation, and improved cardiac performance. So pass on my positive news!

Israel’s Sheba Medical Center was ranked 10th in Newsweek’s latest list of the world’s smartest hospitals, having risen from 13th (see previously). Sheba’s standout categories were Robotics and Telemedicine.

Israel’s Magen David Adom is training some 1,000 Wolt delivery drivers in CPR, treating injuries, how to stop bleeding, etc., and giving them life-saving first aid tools. Wolt drivers often encounter emergencies all over Israel, in which first aid training could be vital.

Israel’s Epitomee (see previously) has received US-FDA  marketing approval for its pill that expands in the stomach, making it feel full and discourage overeating.

Researchers at Israel’s Technion Institute have developed a model to predict problems involving proteins that can lead to Alzheimer’s, Parkinson’s and other brain diseases. This model could serve as a basis for designing new proteins that can treat these diseases.

Israeli researchers have discovered that a common pollutant (perchlorate salts – found in pesticides and automobiles) interferes with the proper functioning of the thyroid gland, leading to hypothyroidism. They built a detection device that uses a receptor molecule to alert to pollutant’s presence.

Israel’s PainReform (see previously) has developed new improved anti-inflammatory properties for its PRF-110 pain relief treatment. These have then been successfully tested in a Phase 3 multi-site US trial of 443 patients undergoing bunionectomy surgery.

Researchers at Israel’s Sheba Medical Center have created LIV - a new generative AI-based platform offering personalized patient interactions and effective diagnostics to people with PTSD, depression, anxiety, and other mental health issues. It reduces bottlenecks from an acute shortage of mental health experts.

Researchers at Ben Gurion University and Israel’s Sheba Medical Center used AI to detect nearly 2,000 patients at high risk of developing a pulmonary embolism (lung blood clot). Sheba used the BGU algorithm to analyze the records of 46,000 patients who were admitted to ER.

Israel’s Endospan (see previously) shared good early news from the trial on 22 patients of its Nexus Aortic Arch Stent Graft System. The trial is being extended to 110 patients. 120,000+ patients suffer thoracic aortic arch disease every year in the USA and Europe.